Literature DB >> 26115132

[Current strategies against multi-drug resistant organisms].

Mathias W Pletz1, Christian Eckmann2, Stefan Hagel1, Hans Jürgen Heppner3, Kora Huber4, Wolfgang Kämmerer5, Franz-Josef Schmitz6, Michael Wilke7, Béatrice Grabein8.   

Abstract

The global spread of multi-drug resistant organisms (MDRO) is a major threat to public health. Fighting MDRO spread requires a multi-faceted approach as summarized in the German Antibiotic Resistance Strategy (DART). In the hospital, this includes antibiotic stewardship concepts and strict infection control measures. Treatment of MDRO is sophisticated. Within the last years, several antibiotics with activity against MRSA were launched and facilitate an individual therapy according to site of infection and co-morbidities. In contrast, novel antibiotics against carbapenemase producing Gram-negatives are still lacking. Current studies have shown, that a colistin-based combination treatment can improve the prognosis in these patients. The following article reviews MDRO definitions, burden of disease, treatment options and general strategies against MDRO. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26115132     DOI: 10.1055/s-0041-102452

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  5 in total

1.  Bad bacteria in acute appendicitis: rare but relevant.

Authors:  Alexander Reinisch; Patrizia Malkomes; Nils Habbe; Wolf Otto Bechstein; Juliane Liese
Journal:  Int J Colorectal Dis       Date:  2017-07-15       Impact factor: 2.571

2.  [Multidrug resistant bacteria in the intensive care unit : Reasonable measures for prevention].

Authors:  R Fussen; S Lemmen
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-10-20       Impact factor: 0.840

3.  Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship.

Authors:  Steffen Lebentrau; Christian Gilfrich; Malte W Vetterlein; Harald Schumacher; Philipp J Spachmann; Sabine D Brookman-May; Hans M Fritsche; Martin Schostak; Florian M Wagenlehner; Maximilian Burger; Matthias May
Journal:  Int Urol Nephrol       Date:  2017-04-21       Impact factor: 2.370

Review 4.  [Antibiotic therapy of intra-abdominal infections in the era of multiresistance].

Authors:  C Eckmann
Journal:  Chirurg       Date:  2016-01       Impact factor: 0.955

5.  Awareness and perception of multidrug-resistant organisms and antimicrobial therapy among internists vs. surgeons of different specialties: Results from the German MR2 Survey.

Authors:  Philipp J Spachmann; Matthias May; Malte W Vetterlein; Hans-Martin Fritsche; Steffen Steffen; Martin Schostak; Florian M Wagenlehner; Maximilian Burger; Karsten-Henrich Weylandt; Bernd Salzberger; Sabine D Brookman-May; Christian Gilfrich
Journal:  Caspian J Intern Med       Date:  2019
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.